By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Anacor Pharmaceuticals, Inc. 

1060 East Meadow Circle

Palo Alto  California  94303  U.S.A.
Phone: 650-739-0700 Fax: 650-739-0139


SEARCH JOBS


Industry
Pharmaceutical






Company News
3 Depressed Biotechs that Investors with a Long-Term Perspective Should Buy Right Now 4/11/2016 6:36:51 AM
Anacor (ANAC) Announces Proposed Offering Of $250 Million Of Convertible Senior Notes Due 2023 3/31/2016 11:01:31 AM
Anacor (ANAC) Announces FDA Acceptance Of NDA For Crisaborole Topical Ointment, 2% For The Treatment Of Mild-To-Moderate Atopic Dermatitis 3/22/2016 10:55:06 AM
Anacor (ANAC) To Present At The Cowen and Company 36th Annual Health Care Conference 3/4/2016 10:47:32 AM
Anacor (ANAC) Reports 2015 Fourth Quarter And Year-End Financial Results 3/1/2016 11:35:17 AM
Anacor (ANAC) Announces Late-Breaking Oral Presentation Of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data At The 74th Annual Meeting Of The American Academy of Dermatology 2/24/2016 11:06:59 AM
Anacor (ANAC) Announces 2015 Fourth Quarter And Year-End Financial Results Conference Call And Webcast 2/23/2016 10:53:00 AM
Anacor (ANAC) To Present Data From Long-Term Safety Study Of Crisaborole Topical Ointment, 2% In Patients With Mild-To-Moderate Atopic Dermatitis At Upcoming Medical Conference 1/8/2016 9:34:41 AM
Anacor (ANAC) To Present Data From Long-Term Safety Study Of Crisaborole Topical Ointment, 2% In Patients With Mild-To-Moderate Atopic Dermatitis At Upcoming Medical Conference 1/8/2016 8:15:44 AM
Anacor (ANAC) Submits New Drug Application To The FDA For Crisaborole Topical Ointment, 2% For The Treatment Of Mild-To-Moderate Atopic Dermatitis 1/7/2016 10:55:21 AM
12345678910...
//-->